Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 12/1/1990


1.		Phase II Master Protocol for Advanced, Recurrent Gynecologic Malignancies: Aminothiadiazole in Patients with Uterine Sarcoma (Summary Last Modified 12/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				GOG-26Q


2.		Master Protocol for Phase II Evaluation of New Agents for Unresectable non-Small Cell Lung Cancer --- Aminothiadiazole

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D82-012-1031 ICC-81L2

Last Modified: 4/26/2007


3.		Phase II Master Protocol for Chemotherapy for Recurrent or Stage IV Renal Cell Carcinoma --- VBL vs L-Alanosine vs Acivicin vs CTX vs Misonidazole vs Aminothiadiazole

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				EST-1882


4.		Phase II Master Protocol for Evaluation of New Agents for Previously Treated Metastatic Breast Cancer --- AT-125, A-TDA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				EST-2182


5.		Phase II Master Protocol Chemotherapy with New Agents for Metastatic or Recurrent Colorectal Cancer --- ATDA vs ICRF-187 vs SPG and CHIP vs CBDCA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				EST-4282


6.		Phase II Master Protocol for Chemotherapy with New Agents for Metastatic or Recurrent Adenocarcinoma of the Colon or Rectum --- ATDA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D82-012-1346 ICC-79I2

Last Modified: 11/7/2007


7.		Phase II Chemotherapy with 2-Aminothiadiazole in Patients with Inoperable non-Small Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								NCI-W82-1276 CTEPIS-0059, W82-1276

Last Modified: 1/1/1990


8.		Phase II Master Protocol for Chemotherapy with New Agents for Advanced non-Hodgkin's Lymphoma --- ATDA (Summary Last Modified 01/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				ICC-83H2 NCI-T83-0924D, T83-0924


9.		Phase II Master Protocol Evaluation of Single-Agent or Combination Chemotherapy for Advanced Squamous Cell Carcinoma of the Esophagus --- ATDA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				EST-1284

Last Modified: 5/1/1989


10.		Phase II Chemotherapy with Aminothiadiazole in Patients with Advanced Colorectal Carcinoma (Summary Last Modified 05/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ICC-88I2 NCI-T88-0068D, T88-0068

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute